Related Experiment Video
Updated: Jan 2, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Stroke after transcatheter edge-to-edge mitral valve repair: a systematic review and meta-analysis
Patricia Barros da Silva1, José P Sousa, Bárbara Oliveiros
1Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal.
Insights
Transcatheter mitral valve repair (TMVR) shows a trend toward lower stroke risk compared to surgical mitral valve repair (SMVR), with similar stroke rates to optimal medical treatment (OMT) for severe mitral regurgitation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Severe mitral regurgitation necessitates effective treatment to prevent adverse outcomes.
- Transcatheter mitral valve repair (TMVR) offers a less invasive alternative to surgical repair.
- Comparing stroke rates across different mitral valve repair strategies is crucial for patient management.
Purpose of the Study:
- To evaluate and compare the stroke rate following TMVR using the MitraClip device.
- To compare TMVR outcomes against surgical mitral valve repair (SMVR) and optimal medical treatment (OMT).
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, Embase, Cochrane).
- Random-effects and cumulative meta-analysis of ten studies involving 1,881 patients.
- Stroke incidence was pooled and analyzed for TMVR vs. SMVR and TMVR vs. OMT.
Main Results:
- No statistically significant difference in stroke incidence was observed between TMVR and SMVR (OR 0.49, p=0.19), though a trend favored TMVR.
- TMVR demonstrated a similar stroke rate compared to OMT (OR 1.09, p=0.79).
- De novo atrial fibrillation was more frequent after SMVR than TMVR.
Conclusions:
- While not statistically significant, TMVR showed a trend towards a lower stroke rate post-procedure compared to SMVR.
- TMVR and OMT yielded comparable stroke rates for severe mitral regurgitation.
- TMVR may offer a favorable stroke profile in managing mitral regurgitation.
Aims:
The aim of this study was to assess the stroke rate after transcatheter mitral valve repair (TMVR) with the MitraClip, comparing it with surgical mitral valve repair (SMVR) and optimal medical treatment (OMT).
Methods And Results:
In December 2018, we systematically searched PubMed, Embase and Cochrane Controlled Register of Trials for studies comparing TMVR with SMVR and/or OMT for the treatment of severe mitral regurgitation. Random-effects and cumulative meta-analysis was performed. Ten studies were included (seven of TMVR versus SMVR and three of TMVR versus OMT), providing a total of 1,881 patients and 61 pooled strokes (16 in TMVR versus SMVR and 45 in TMVR versus OMT). There was no difference in stroke incidence between TMVR and SMVR (pooled OR 0.49 [0.17, 1.42], p=0.19). However, there was a trend towards a lower stroke risk in TMVR. For TMVR versus OMT, no difference in stroke rate was identified (pooled OR 1.09 [0.60, 1.97], p=0.79). Post-procedure de novo atrial fibrillation was more frequent in SMVR when compared with TMVR.
Conclusions:
Despite both a low number of pooled stroke events and the failure to reach the pre-specified statistical significance, there was a trend for a lower post-procedure stroke rate in TMVR when compared with SMVR and a similar one between TMVR and OMT alone.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction

